TRIM47 and non-small cell lung carcinoma: The GEO dataset (GSE31210, Figure 1C, 1D) and the TCGA dataset (Figure 1E, 1F) illustrated that higher TRIM47 expression predicted poor relapse-free survival and overall survival in early stage and advanced stage NSCLC, respectively.